Biopharmaceutics & drug disposition - JoVE Visualize

Showing results (401-410 of 2,132) with videos related to

Pageof 214

Sort By:

Biopharmaceutics & Drug Disposition|January 1, 1990

Effect of dietary fat content on the bioavailability of a sustained release quinidine gluconate tabletM N Martinez, F R Pelsor, V P Shah, et al.

Biopharmaceutics & Drug Disposition|January 1, 1990

Absence of effect of food on alprazolam absorption from sustained release tabletsM G Eller, A A Della-Coletta

Biopharmaceutics & Drug Disposition|January 1, 1990

Absolute bioavailability of terbutaline from a CR-granulate in asthmatic childrenG Fuglsang, B Hertz, E B Holm, et al.

Biopharmaceutics & Drug Disposition|March 1, 1990

Influence of food on the bioavailability of diltiazem and two of its metabolites following the administration of conventional tablets and slow-release capsulesP Du Souich, N Lery, L Lery, et al.

Biopharmaceutics & Drug Disposition|March 1, 1990

Bioavailability of a new sustained-release theophylline capsule in fasted and non-fasted healthy subjects: single and multiple dosing studiesR J West, G Boehm, M Dwyer, et al.

Biopharmaceutics & Drug Disposition|April 1, 1990

Diphenhydramine kinetics following intravenous, oral, and sublingual dimenhydrinate administrationJ M Scavone, B G Luna, J S Harmatz, et al.

Biopharmaceutics & Drug Disposition|April 1, 1990

Absorption and disposition of a new low-dose combination formulation of hydrochlorothiazide and triamtereneR L Williams, E T Lin, W Liang-Gee, et al.

Biopharmaceutics & Drug Disposition|April 1, 1990

First-pass metabolism of acetaminophen in rats after low and high dosesJ Hirate, C Y Zhu, I Horikoshi, et al.

Biopharmaceutics & Drug Disposition|January 15, 2013

Reviewing the binding of a series of parabens to human serum albuminHélène Greige-Gerges, Rana Kaissi, Jacques Magdalou, et al.

Biopharmaceutics & Drug Disposition|October 10, 2014

Evaluation of the likelihood of a selective CHK1 inhibitor (LY2603618) to inhibit CYP2D6 with desipramine as a probe substrate in cancer patientsScott M Hynes, Enaksha Wickremsinhe, Wei Zhang, et al.

Pageof 214

Showing results (401-410 of 2,132) with videos related to

Sort By:

Pageof 214

Biopharmaceutics & Drug Disposition|January 1, 1990

Effect of dietary fat content on the bioavailability of a sustained release quinidine gluconate tabletM N Martinez, F R Pelsor, V P Shah, et al.

Biopharmaceutics & Drug Disposition|January 1, 1990

Absence of effect of food on alprazolam absorption from sustained release tabletsM G Eller, A A Della-Coletta

Biopharmaceutics & Drug Disposition|January 1, 1990

Absolute bioavailability of terbutaline from a CR-granulate in asthmatic childrenG Fuglsang, B Hertz, E B Holm, et al.

Biopharmaceutics & Drug Disposition|March 1, 1990

Influence of food on the bioavailability of diltiazem and two of its metabolites following the administration of conventional tablets and slow-release capsulesP Du Souich, N Lery, L Lery, et al.

Biopharmaceutics & Drug Disposition|March 1, 1990

Bioavailability of a new sustained-release theophylline capsule in fasted and non-fasted healthy subjects: single and multiple dosing studiesR J West, G Boehm, M Dwyer, et al.

Biopharmaceutics & Drug Disposition|April 1, 1990

Diphenhydramine kinetics following intravenous, oral, and sublingual dimenhydrinate administrationJ M Scavone, B G Luna, J S Harmatz, et al.

Biopharmaceutics & Drug Disposition|April 1, 1990

Absorption and disposition of a new low-dose combination formulation of hydrochlorothiazide and triamtereneR L Williams, E T Lin, W Liang-Gee, et al.

Biopharmaceutics & Drug Disposition|April 1, 1990

First-pass metabolism of acetaminophen in rats after low and high dosesJ Hirate, C Y Zhu, I Horikoshi, et al.

Biopharmaceutics & Drug Disposition|January 15, 2013

Reviewing the binding of a series of parabens to human serum albuminHélène Greige-Gerges, Rana Kaissi, Jacques Magdalou, et al.

Biopharmaceutics & Drug Disposition|October 10, 2014

Evaluation of the likelihood of a selective CHK1 inhibitor (LY2603618) to inhibit CYP2D6 with desipramine as a probe substrate in cancer patientsScott M Hynes, Enaksha Wickremsinhe, Wei Zhang, et al.

Pageof 214